October 17, 2022

Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.

June 6, 2022

The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.

Carl Fichtenbaum, a professor in the Division of Infectious Diseases at the University of Cincinnati College of Medicine and one of the leaders in UC’s efforts to combat COVID-19, is still going to protest marches as his passion for social justice, personally and profession- ally, burns as brightly as ever.